Literature DB >> 23407563

Esophagitis: a novel adverse event of crizotinib in a patient with ALK-positive non-small-cell lung cancer.

Neeharika Srivastava1, Paul A VanderLaan, Ciaran P Kelly, Daniel B Costa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23407563     DOI： 10.1097/JTO.0b013e31827e2451

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  4 in total

1.  Managing treatment-related adverse events associated with Alk inhibitors.

Authors:  J M Rothenstein; N Letarte
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

2.  Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review.

Authors:  Patrick Jung; Kyle J Fortinsky; Zane R Gallinger; Piero Tartaro
Journal:  Case Rep Gastrointest Med       Date:  2016-12-08

3.  Severe Ulcerative Esophagitis Induced by Crizotinib Therapy.

Authors:  Ala' A Abdel Jalil; Jamie Craig; Rajesh Bajaj; Timothy Spurling
Journal:  ACG Case Rep J       Date:  2014-01-10

4.  Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report.

Authors:  F Guisier; N Piton; M Bellefleur; N Delberghe; G Avenel; E Angot; O Vittecoq; M Ould-Slimane; H Morisse-Pradier; M Salaun; L Thiberville
Journal:  BMC Cancer       Date:  2020-01-06       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.